Company Description
Valeo Pharma (OTC Link: VPHIF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $4.6M.
VPHIF stock has declined 100.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of VPHIF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Valeo Pharma (VPHIF) stock last traded at $0.0000. Over the past 12 months, the stock has lost 100.0%. At a market capitalization of $4.6M, VPHIF is classified as a micro-cap stock with approximately 98.7M shares outstanding.
Latest News
Valeo Pharma has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 2 with negative movement. Key topics include covid-19, clinical trial, conferences, earnings. View all VPHIF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Valeo Pharma (VPHIF) currently stands at 35 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Valeo Pharma (VPHIF) currently stands at 1.0 days. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The days to cover has decreased 99.9% over the past year, suggesting improved liquidity for short covering. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
VPHIF Company Profile & Sector Positioning
Valeo Pharma (VPHIF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing VPHIF often look at related companies in the same sector, including Abattis Bioceuticals Corp (ATTBF), TREES CORP (CANN), Sunniva (SNNVF), Delivra Health (DHBUF), and 1933 Inds (TGIFF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate VPHIF's relative position within its industry.